Cullinan Therapeutics Inc.
Cullinan Therapeutics develops T cell engagers for autoimmune diseases and cancer.
10-QNov 16Latest SEC filing
Nov 17Latest story
November 2026
October 2026
August 2026
July 2026
Cullinan Therapeutics develops T cell engagers for autoimmune diseases and cancer.
November 2026
October 2026
August 2026
July 2026